These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

831 related items for PubMed ID: 28625684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA, Lee CC, Kesselheim AS, Avorn J.
    JAMA; 2018 Aug 21; 320(7):650-656. PubMed ID: 30140875
    [Abstract] [Full Text] [Related]

  • 3. Medicare Part D payments for neurologist-prescribed drugs.
    De Lott LB, Burke JF, Kerber KA, Skolarus LE, Callaghan BC.
    Neurology; 2016 Apr 19; 86(16):1491-8. PubMed ID: 27009256
    [Abstract] [Full Text] [Related]

  • 4. Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.
    Zafar S, Wang P, Schein OD, Srikumaran D, Makary M, Woreta FA.
    Ophthalmology; 2020 May 19; 127(5):573-581. PubMed ID: 31952884
    [Abstract] [Full Text] [Related]

  • 5. Changes in Prices and Eye-Care Providers Prescribing Patterns of Glaucoma Medications in the United States Between 2013 and 2019.
    Barayev E, Geffen N, Nahum Y, Gershoni A.
    J Glaucoma; 2021 Mar 01; 30(3):e83-e89. PubMed ID: 33137023
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program.
    Ma I, Tisdale RL, Vail D, Heidenreich PA, Sandhu AT.
    Circ Cardiovasc Qual Outcomes; 2021 Dec 01; 14(12):e007559. PubMed ID: 34879702
    [Abstract] [Full Text] [Related]

  • 8. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H, Adamson A, Mostaghimi A.
    JAMA Dermatol; 2017 Aug 01; 153(8):755-759. PubMed ID: 28453645
    [Abstract] [Full Text] [Related]

  • 9. Examining Opportunities to Increase Savings From Medicare Price Negotiations.
    Reitsma MB, Dusetzina SB, Ballreich JM, Trujillo AJ, Mello MM.
    JAMA Intern Med; 2023 Jun 01; 183(6):581-588. PubMed ID: 37067794
    [Abstract] [Full Text] [Related]

  • 10. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.
    J Manag Care Spec Pharm; 2014 Mar 01; 20(3):283-90. PubMed ID: 24564812
    [Abstract] [Full Text] [Related]

  • 11. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.
    Sumarsono A, Sumarsono N, Das SR, Vaduganathan M, Agrawal D, Pandey A.
    JAMA Netw Open; 2020 Feb 05; 3(2):e200181. PubMed ID: 32108893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G, Weiss RC.
    Consult Pharm; 2012 Apr 05; 27(4):269-73. PubMed ID: 22498986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.
    Socal MP, Bai G, Anderson GF.
    JAMA Netw Open; 2021 Mar 01; 4(3):e210483. PubMed ID: 33651110
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS, Phillips KA, Gerstenberger EP, Seger AC.
    Ann Intern Med; 2005 Jun 07; 142(11):891-7. PubMed ID: 15941695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.